跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARX-METHOTREXATE 2.5 methotrexate 2.5 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
ARX-METHOTREXATE 2.5 methotrexate 2.5 mg tablet blister pack
Approved
STANDARD
ARX-METHOTREXATE 2.5 methotrexate 2.5 mg tablet blister pack
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
08e024cb1ed05b98
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
08e024cb1ed05b98
Product Name
ARX-METHOTREXATE 2.5 methotrexate 2.5 mg tablet blister pack
Artg Id
365580
Artg Name
ARX-METHOTREXATE 2.5 methotrexate 2.5 mg tablet blister pack
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2023-05-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/11cda0608dedfeb8405baceda5876629.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/604f50471346dea46922372f082ae707.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
08e024cb1ed05b98
Type
Standard
Back to TGA Approvals